U.S. Consumer Finance Stock News

Vistra Corp. recently filed a protest with the Federal Energy Regulatory Commission, arguing that PJM Interconnection’s compliance plan on co-located facilities conflicts with a prior Commission order intended to support reliable, affordable development in the PJM region. The company warns that PJM’s proposed ambiguity on transition rules, delayed implementation until 2029, and complex capacity rights framework could slow integration of co-located projects critical for data centers and...

Realty Income (NYSE:O) closed a $694 million long term unsecured term loan with Goldman Sachs. The facility supports a municipal prepay transaction for San Diego Community Power, tied to community power infrastructure. The structure uses long dated, fixed rate financing and cross currency swaps to target a lower blended cost of debt. Realty Income, trading at $60.06, is adding this Goldman Sachs term loan to its funding toolkit at a time when its 1 year return stands at 12.2% and its 5 year...

Earlier in March, Evercore announced the hire of David Ke as a senior managing director in its equity capital markets group focused on biotechnology, and the firm recently participated in the 2026 Life Science Intelligence Summit through a healthcare investment banking presentation by Bennett Blau. These developments highlight Evercore’s growing emphasis on healthcare and biotechnology advisory and capital-raising capabilities, reinforcing its presence in life sciences investment...

Stock performance context for Las Vegas Sands Las Vegas Sands (LVS) has attracted fresh attention as investors reassess casino and resort operators, with the stock recently closing at US$54.17 and showing mixed returns over the past year and multi year periods. Over the past month, Las Vegas Sands has recorded a 3% decline, while the past 3 months show an 18.3% negative return. Year to date, the stock is down 16.9%, although the 1 year total return stands at 37.2%. Looking at a longer window,...

Workday stock performance snapshot Workday (WDAY) has been under pressure recently, with the share price down about 2% over the past week and roughly 41% over the past 3 months, while year-to-date returns sit near 38% lower. See our latest analysis for Workday. At a share price of US$127.07, Workday’s recent trend points to fading momentum. The 90 day share price return is 41.4% and the 1 year total shareholder return is 49.3% lower, indicating investors have reassessed both growth prospects...

Johnson & Johnson (NYSE:JNJ) has approved another dividend increase, supported by what it reports as strong free cash flow. The company is rebalancing its portfolio, exiting stakes in several biotech partners, including former collaborators. A recent California court ruling in talc litigation reduced punitive damages while maintaining compensatory damages, and JNJ plans to appeal. Johnson & Johnson, a large healthcare group with operations spanning pharmaceuticals, medical technologies and...

Arm Holdings (NasdaqGS:ARM) has introduced its first in-house AI data center chip, the AGI CPU. The chip is designed for AI workloads in data centers and was developed with Meta as a lead partner. The move expands Arm’s role from licensing semiconductor IP to offering its own production silicon. The launch targets the growing demand for AI infrastructure across large technology platforms. Arm has long been known for designing energy efficient processor architectures that sit inside...

Uber Technologies (NYSE:UBER) has entered a multi year exclusive digital promotions partnership with Ibotta across the U.S. The agreement embeds personalized promotions and coupons into Uber Eats and is expected to extend across the Uber and Postmates apps. The partnership connects consumer packaged goods brands directly with shoppers at the point of purchase inside Uber’s delivery ecosystem. For Uber Technologies, this move fits directly into its push beyond ride hailing into grocery and...

Biolojic Design recently announced that TEV ‘325, a multibody targeting IL-13 and TSLP for TH2-driven inflammatory diseases, achieved a preclinical milestone in its collaboration with Teva, triggering milestone payments and confirming Teva’s exclusive global development and commercialization rights. This milestone underscores Teva’s progress in innovative biologics, adding scientific and commercial depth to its inflammatory disease pipeline alongside its established generics and branded...

Recent performance snapshot for New Oriental Education & Technology Group (EDU) New Oriental Education & Technology Group (NYSE:EDU) has attracted attention after a 2.2% move over the past day, set against mixed recent returns that include a 5.1% decline over the past month and a small gain over the past 3 months. See our latest analysis for New Oriental Education & Technology Group. That latest 2.2% daily share price gain comes after a softer patch, with a 30 day share price return of 5.1%...

Event context and recent share performance EPR Properties (EPR) has attracted investor attention after recent trading left the shares about 1.7% lower on the day and roughly 10% lower over the past week. Over the past month, the stock shows a decline of about 16%. The past 3 months and year to date have been comparatively steadier, with total return over the past year modestly positive. See our latest analysis for EPR Properties. The recent 16.1% 1 month share price decline has pulled...

Ranchland Capital Partners recently selected SEI Investments to provide fund administration and investor services for its alternative fund offerings, outsourcing key operational functions to SEI’s technology-enabled platform. This mandate underscores SEI’s growing role as an outsourced partner to alternative asset managers, reinforcing its focus on scalable technology, back-office efficiency, and long-term client relationships. We’ll now examine how supporting Ranchland’s alternative fund...

Wondering if Viking Therapeutics at around US$33.20 is still offering value after a strong multi year run, or if the easy gains are already behind it. The stock has seen a 1% decline over the past week and a 3.7% decline over the last month, even with a 26% return over the past year and a very large gain over five years. Recent attention on Viking Therapeutics has been driven by its role in the pharmaceuticals and biotech space. In this area, clinical progress, partnerships, or regulatory...

How Rockwell Automation’s Recent Performance Frames Today’s Valuation Rockwell Automation (ROK) has seen mixed share performance recently, with a 7% decline over the past month and a 9.4% decline over the past 3 months, despite a 36% total return over the past year. At a last close of US$360.65 and a market cap around US$40.6b, the company sits against a backdrop of reported annual revenue of US$8.57b and net income of US$988 million. See our latest analysis for Rockwell Automation. Rockwell...

Earlier in March 2026, AXT Inc. reported that Director Jesse Chen had sold common stock in several open‑market transactions, reducing his directly held position by 41.43% since March 5 and leaving him with 109,526 shares. At the same time, AXT’s management highlighted strong progress in export permits, robust indium phosphide demand, and plans to double manufacturing capacity while expanding its customer base to Tier‑1 companies, reshaping how investors may view its growth prospects and...

Earlier in March 2026, PROCEPT BioRobotics highlighted that the European Association of Urology has upgraded Aquablation therapy to a strong recommendation as a surgical option for men with benign prostatic hyperplasia, positioning it as an alternative to transurethral resection of the prostate, especially for those seeking to preserve ejaculatory function. This guideline upgrade, backed by multiple WATER clinical trials and growing international validation including NICE support in the UK,...

Hecla Mining (NYSE:HL) has completed the sale of its Casa Berardi Mine subsidiary. The company plans to fully redeem its remaining senior notes following the transaction. These moves are intended to reduce debt and reshape Hecla’s asset mix around its core silver operations. For investors watching NYSE:HL, this news comes with the stock trading at $18.36 after a strong multi year run, including a very large 5 year gain. Over the past month, the share price has declined 23.5%, even though...

Shareholder proposals at Colgate-Palmolive's May 2026 annual meeting seek to separate the roles of Chairman and CEO. Another proposal asks the company to remove diversity, equity, and inclusion criteria from board candidate selection. Colgate-Palmolive's board has recommended shareholders vote against these changes, setting up a governance and policy debate. Colgate-Palmolive (NYSE: CL) heads into its May 2026 meeting with its share price at $85.49 and a value score of 2, signaling mixed...

Accenture (NYSE:ACN) has launched Cyber.AI, an enterprise-focused cybersecurity platform powered by generative AI, including Anthropic’s Claude. The company is also investing in DaVinci Commerce to support AI-based, agentic commerce solutions for clients. These moves expand Accenture’s use of AI across both security operations and digital commerce offerings. For investors watching how large IT services players are using AI in real client work, Accenture’s Cyber.AI launch sits at the...

Radian Group (RDN) has drawn fresh attention after recent share performance, with the stock roughly flat over the past week but showing a decline over the month and past 3 months. Investors are reassessing its mortgage insurance profile. See our latest analysis for Radian Group. At a share price of $32.97, Radian Group’s recent 30 day and 90 day share price returns of 3.79% and 10.09% declines suggest fading short term momentum, even as the 3 year total shareholder return of 66.60% points to...

Encompass Health Corp. has announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Bear, Delaware, expanding its network and adding its second location in the state to serve patients with complex neurological, orthopedic and other debilitating conditions. The facility’s focus on advanced rehabilitation technologies, specialized clinical teams and comprehensive in-house services such as dialysis underlines Encompass Health’s emphasis on higher-acuity, medically...

If you are wondering whether Archer-Daniels-Midland's current share price actually lines up with its underlying worth, the next sections will walk through that question in a structured way. The stock last closed at US$71.66, with returns of 1.1% over the past week, 5.9% over the past month, 21.4% year to date and 57.6% over the past year. These figures can affect how comfortable you feel about the current entry point. Recent coverage around Archer-Daniels-Midland has focused on its role in...

In March 2026, Halliburton, together with ExxonMobil, Sekal, Noble and the Wells Alliance Guyana team, completed the industry’s first fully automated geological well placement with complete rig automation in offshore Guyana, integrating LOGIX orchestration, EarthStar ultra-deep resistivity and Sekal’s DrillTronics into a single closed-loop system. This project underscored how unifying subsurface insight, real-time automation and rig systems can materially improve well construction efficiency...

Earlier this week, Oppenheimer expressed confidence that Aramark’s upcoming early-May earnings will be “clean,” highlighting solid performance across its business, education, and healthcare divisions, as well as effective management of labor and food costs. At the same time, Aramark’s fresh slate of fan-focused food concepts and experiences across multiple Major League Baseball stadiums underscores how product innovation in Sports & Entertainment could reinforce its broader contract-based...